The invention relates to new formulations for improving the local tolerance of intravenously administered 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine or one of the pharmacologically acceptable acid addition salts thereof.

 
Web www.patentalert.com

< Nucleic acids encoding antagonists of interleukin-15

< Nucleic acid fragment, recombinant vector containing the same and method of promoting the expression of structural genes by using the same

> Chimeric proteins for diagnosis and treatment of diabetes

> Gene encoding protein having aurone synthesizing activity
~ 00231